zafirlukast [Ligand Id: 3322] activity data from GtoPdb and ChEMBL
Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
| ChEMBL ligand: CHEMBL603 (Accolate, Ici-204,219, ICI 204,219, ICI-204219, Zafirlukast) |
|---|
|
There should be some charts here, you may need to enable JavaScript!
|
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
| DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
|---|---|---|---|---|---|---|---|---|
| A1 receptor/Adenosine A1 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL226] [GtoPdb: 18] [UniProtKB: P30542] | ||||||||
| ChEMBL | Inhibitory concentration against Adenosine A1 receptor | B | 5 | pIC50 | >10000 | nM | IC50 | Bioorg Med Chem Lett (1995) 5: 1377-1382 |
| A3 receptor/Adenosine A3 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL256] [GtoPdb: 21] [UniProtKB: P0DMS8] | ||||||||
| ChEMBL | DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA) | B | 6.11 | pKi | 770 | nM | Ki | DrugMatrix in vitro pharmacology data |
| ChEMBL | DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA) | B | 5.87 | pIC50 | 1363 | nM | IC50 | DrugMatrix in vitro pharmacology data |
| Farnesoid X receptor/Bile acid receptor FXR in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2047] [GtoPdb: 603] [UniProtKB: Q96RI1] | ||||||||
| ChEMBL | Agonist activity at FXR in human HeLa cells incubated for 24 hrs by Dual-Glo luciferase assay | B | 5.41 | pEC50 | 3900 | nM | EC50 | J Med Chem (2021) 64: 17545-17571 [PMID:34889100] |
| Sodium/bile acid and sulphated solute cotransporter 1/Bile acid transporter in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5287] [GtoPdb: 959] [UniProtKB: Q14973] | ||||||||
| ChEMBL | Inhibition of HA-tagged human NTCP expressed in human U2OS cells assessed as reduction in [14C]taurocholate uptake preincubated for 10 mins followed by [14C] taurocholate addition and further incubation for 10 mins by scintillation counting method | B | 5.19 | pIC50 | 6500 | nM | IC50 | Bioorg Med Chem Lett (2019) 29: 126623-126623 [PMID:31439379] |
| ChEMBL | Inhibition of human NTCP mediated TCA uptake in U2OS expresseing HA-tagged NTCP cells preincubated for 10 mins followed by substrate addition and measured after 2 mins using [3H]-taurocholate as substrate by liquid scintillation counter analysis | B | 5.19 | pIC50 | 6500 | nM | IC50 | J Med Chem (2022) 65: 12546-12561 [PMID:36111355] |
| ChEMBL | Inhibition of preS1-peptide binding to human HA-tagged NTCP in U2OS expresseing NTCP in incubated for 24 hrs using Myrcludex B as substrate by competitive binding assay | B | 6 | pIC50 | >1000 | nM | IC50 | J Med Chem (2022) 65: 12546-12561 [PMID:36111355] |
| CysLT1 receptor/Cysteinyl leukotriene receptor 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1798] [GtoPdb: 269] [UniProtKB: Q9Y271] | ||||||||
| GtoPdb | against [3H]LTD4 in human lung parenchyma | - | 8.9 | pKi | - | - | - |
Biochem Pharmacol (2002) 63: 1537-46 [PMID:11996896]; Br J Pharmacol (1998) 123: 590-8 [PMID:9504401] |
| ChEMBL | DRUGMATRIX: Cysteinyl leukotriene receptor 1 radioligand binding (ligand: [3H]LTD4) | B | 9.06 | pKi | 0.86 | nM | Ki | DrugMatrix in vitro pharmacology data |
| GtoPdb | - | - | 7.7 | pIC50 | 20 | nM | IC50 | Br J Pharmacol (2010) 160: 399-409 [PMID:20423349] |
| ChEMBL | Antagonist activity against CysLT1 receptor (unknown origin) expressed in HEK293 cells assessed as inhibition of LTD4-induced calcium mobilization pre-incubated for 10 mins before LTD4 addition by Fluo-4 AM dye based fluorimetric assay | F | 7.85 | pIC50 | 14 | nM | IC50 | ACS Med Chem Lett (2016) 7: 335-339 [PMID:26985325] |
| ChEMBL | Antagonist activity at human CysLT1 | B | 8.72 | pIC50 | 1.9 | nM | IC50 | J Med Chem (2015) 58: 6093-6113 [PMID:26200813] |
| GtoPdb | against [3H]LTD4 in COS-7 or HEK-293 cells | - | 8.74 | pIC50 | 1.8 | nM | IC50 |
Nature (1999) 399: 789-93 [PMID:10391245]; Mol Pharmacol (1999) 56: 657-63 [PMID:10462554] |
| ChEMBL | Inhibition of cysteinyl leukotriene receptor 1 (unknown origin) expressed in HEK293 cell membranes after 45 mins by scintillation spectrometry | B | 8.74 | pIC50 | 1.8 | nM | IC50 | J Med Chem (2017) 60: 5235-5266 [PMID:28252961] |
| ChEMBL | DRUGMATRIX: Cysteinyl leukotriene receptor 1 radioligand binding (ligand: [3H]LTD4) | B | 8.76 | pIC50 | 1.73 | nM | IC50 | DrugMatrix in vitro pharmacology data |
| ChEMBL | Antagonist activity at human CysLT1 receptor | F | 9.59 | pIC50 | 0.26 | nM | IC50 | J Med Chem (2021) 64: 16512-16529 [PMID:34767347] |
| GtoPdb | - | - | 9.59 | pIC50 | 0.26 | nM | IC50 | Mol Pharmacol (1999) 56: 657-63 [PMID:10462554] |
| Cysteinyl leukotriene receptor 1 in Guinea pig (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5645] [UniProtKB: Q2NNR5] | ||||||||
| ChEMBL | Displacement of [3H]leukotriene D4 (LTD4) from receptor in guinea pig lung membranes | B | 8.64 | pKi | 2.3 | nM | Ki | Bioorg Med Chem Lett (1995) 5: 1377-1382 |
| ChEMBL | In vitro binding of cysLT1 receptor to guinea pig lung membranes. | B | 8.7 | pKi | 2 | nM | Ki | Bioorg Med Chem Lett (1999) 9: 2773-2778 [PMID:10509933] |
| ChEMBL | Antagonism of Cysteinyl leukotriene receptor 1 from guinea pig lung membranes | F | 8.7 | pKi | 2 | nM | Ki | Bioorg Med Chem Lett (1998) 8: 3577-3582 [PMID:9934474] |
| ChEMBL | Inhibition constant for displacement of [3H]LTD4 on guinea pig lung parenchymal membranes | B | 9.47 | pKi | 0.34 | nM | Ki | J Med Chem (1994) 37: 1282-1297 [PMID:8176706] |
| ChEMBL | Displacement of [3H]LTD4 from cysteinyl leukotriene receptor 1 in Hartley guinea pig parenchymal membrane after 30 mins by liquid scintillation counting method | B | 9.52 | pKi | 0.3 | nM | Ki | J Med Chem (2017) 60: 5235-5266 [PMID:28252961] |
| ChEMBL | Binding affinity towards Cysteinyl leukotriene D4 receptor (cysLT1) was measured by the displacement of [3H]LTD4 radioligand | B | 9.52 | pKi | 0.3 | nM | Ki | J Med Chem (1998) 41: 1439-1445 [PMID:9554877] |
| ChEMBL | Compound was evaluated for its ability to displace [3H]LTD4 from Cysteinyl leukotriene D4 receptor in guinea pig lung membranes | B | 9.52 | pKi | 0.3 | nM | Ki | J Med Chem (1991) 34: 1235-1242 [PMID:1849993] |
| ChEMBL | Displacement of [3H]LTD4 on guinea pig lung parenchymal membranes | B | 9.52 | pKi | 0.3 | nM | Ki | J Med Chem (1990) 33: 1781-1790 [PMID:2342072] |
| ChEMBL | In vitro inhibition of [3H]LTD4 binding to guinea pig lung membrane | B | 7.36 | pIC50 | 44 | nM | IC50 | Bioorg Med Chem Lett (1998) 8: 965-970 [PMID:9871521] |
| ChEMBL | Binding affinity against leukotriene D4 receptor in [3H]LTD4 binding assay | B | 8.7 | pIC50 | 2 | nM | IC50 | Bioorg Med Chem Lett (1998) 8: 2451-2456 [PMID:9873560] |
| ChEMBL | Concentration required for inhibition of binding of [3H]LTD4 to guinea pig lung membranes | B | 9.36 | pIC50 | 0.44 | nM | IC50 | Bioorg Med Chem Lett (1995) 5: 283-288 |
| CysLT2 receptor/Cysteinyl leukotriene receptor 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4330] [GtoPdb: 270] [UniProtKB: Q9NS75] | ||||||||
| ChEMBL | Antagonist activity against CysLT2 receptor (unknown origin) expressed in HEK293 cells assessed as inhibition of LTD4-induced calcium mobilization pre-incubated for 10 mins before LTD4 addition by Fluo-4 AM dye based fluorimetric assay | F | 4.24 | pIC50 | 58000 | nM | IC50 | ACS Med Chem Lett (2016) 7: 335-339 [PMID:26985325] |
| GtoPdb | - | - | 5.13 | pIC50 | 7397 | nM | IC50 | J Biol Chem (2000) 275: 30531-6 [PMID:10851239] |
| ChEMBL | Antagonist activity at human CysLT2 expressed in HEK293T cells assessed as inhibition of LTC4-induced effect preincubated for 30 mins prior to LTC4 addition by Aequorin luminescence assay | B | 5.13 | pIC50 | 7397 | nM | IC50 | J Med Chem (2015) 58: 6093-6113 [PMID:26200813] |
| GtoPdb | - | - | 5.15 | pIC50 | 7000 | nM | IC50 | Br J Pharmacol (2010) 160: 399-409 [PMID:20423349] |
| ChEMBL | Antagonist activity at human CysLT2 receptor | F | 6 | pIC50 | >1000 | nM | IC50 | J Med Chem (2021) 64: 16512-16529 [PMID:34767347] |
| GtoPdb | - | - | 6.9 | pA2 | - | - | - | Prostaglandins Other Lipid Mediat (2015) 120: 115-25 [PMID:25839425] |
| CYP2C9/Cytochrome P450 2C9 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3397] [GtoPdb: 1326] [UniProtKB: P11712] | ||||||||
| ChEMBL | DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) | B | 5.65 | pIC50 | 2257.5 | nM | IC50 | DrugMatrix in vitro pharmacology data |
| cPLA2-4A/Cytosolic phospholipase A2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3816] [GtoPdb: 1424] [UniProtKB: P47712] | ||||||||
| ChEMBL | In vitro inhibition of cystolic phospholipase A2 alpha. | B | 4.07 | pIC50 | 85000 | nM | IC50 | Bioorg Med Chem Lett (2003) 13: 4501-4504 [PMID:14643356] |
| D2 receptor/Dopamine D2 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL217] [GtoPdb: 215] [UniProtKB: P14416] | ||||||||
| ChEMBL | Inhibitory concentration against Dopamine receptor D2 | B | 5 | pIC50 | >10000 | nM | IC50 | Bioorg Med Chem Lett (1995) 5: 1377-1382 |
| epidermal growth factor receptor/Epidermal growth factor receptor erbB1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL203] [GtoPdb: 1797] [UniProtKB: P00533] | ||||||||
| ChEMBL | DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr)) | B | 5.24 | pIC50 | 5751 | nM | IC50 | DrugMatrix in vitro pharmacology data |
| epoxide hydrolase 2/Epoxide hydratase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2409] [GtoPdb: 2970] [UniProtKB: P34913] | ||||||||
| ChEMBL | Inhibition of recombinant human sEH using PHOME as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by spectrofluorimetry | B | 5.7 | pIC50 | 2000 | nM | IC50 | J Med Chem (2018) 61: 5758-5764 [PMID:29878767] |
| ChEMBL | Inhibition of sEH (unknown origin) | B | 5.7 | pIC50 | 2000 | nM | IC50 | J Med Chem (2021) 64: 17545-17571 [PMID:34889100] |
| GtoPdb | - | - | 5.7 | pIC50 | 2000 | nM | IC50 | J Med Chem (2018) 61: 5758-5764 [PMID:29878767] |
| GABAA receptor π subunit/GABAA receptor δ subunit/GABAA receptor α1 subunit/GABAA receptor β1 subunit/GABAA receptor γ2 subunit/GABAA receptor β3 subunit/GABAA receptor α5 subunit/GABAA receptor α3 subunit/GABAA receptor α2 subunit/GABAA receptor β2 subunit/GABAA receptor α4 subunit/GABAA receptor ε subunit/GABAA receptor α6 subunit/GABAA receptor γ1 subunit/GABAA receptor γ3 subunit/GABAA receptor θ subunit/GABA-A receptor; anion channel in Human (target type: PROTEIN COMPLEX GROUP) [ChEMBL: CHEMBL2093872] [GtoPdb: 419, 416, 404, 410, 414, 412, 408, 406, 405, 411, 407, 417, 409, 413, 415, 418] [UniProtKB: O00591, O14764, P14867, P18505, P18507, P28472, P31644, P34903, P47869, P47870, P48169, P78334, Q16445, Q8N1C3, Q99928, Q9UN88] | ||||||||
| ChEMBL | Inhibition of Gamma-aminobutyric acid receptor | B | 5 | pIC50 | >10000 | nM | IC50 | Bioorg Med Chem Lett (1995) 5: 1377-1382 |
| H1 receptor/Histamine H1 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL231] [GtoPdb: 262] [UniProtKB: P35367] | ||||||||
| ChEMBL | Inhibitory concentration against H1 receptor | B | 5 | pIC50 | >10000 | nM | IC50 | Bioorg Med Chem Lett (1995) 5: 1377-1382 |
| mitogen-activated protein kinase 3/MAP kinase ERK1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3385] [GtoPdb: 1494] [UniProtKB: P27361] | ||||||||
| ChEMBL | DRUGMATRIX: Protein Serine/Threonine Kinase, ERK1 enzyme inhibition (substrate: Myelin Basic Protein) | B | 5.36 | pIC50 | 4376 | nM | IC50 | DrugMatrix in vitro pharmacology data |
| mitogen-activated protein kinase 1/MAP kinase ERK2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4040] [GtoPdb: 1495] [UniProtKB: P28482] | ||||||||
| ChEMBL | DRUGMATRIX: Protein Serine/Threonine Kinase, ERK2 enzyme inhibition (substrate: Myelin Basic Protein) | B | 6.27 | pIC50 | 538 | nM | IC50 | DrugMatrix in vitro pharmacology data |
| mitogen-activated protein kinase 14/MAP kinase p38 alpha in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL260] [GtoPdb: 1499] [UniProtKB: Q16539] | ||||||||
| ChEMBL | DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein) | B | 6.45 | pIC50 | 353 | nM | IC50 | DrugMatrix in vitro pharmacology data |
| Multidrug and toxin extrusion/Multidrug and toxin extrusion protein 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1743126] [GtoPdb: 1216] [UniProtKB: Q96FL8] | ||||||||
| ChEMBL | Inhibition of human MATE1-mediated ASP+ uptake expressed in HEK293 cells after 1.5 mins by fluorescence assay | B | 5.89 | pIC50 | 1300 | nM | IC50 | J Med Chem (2013) 56: 781-795 [PMID:23241029] |
| MATE2/Multidrug and toxin extrusion protein 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1743127] [GtoPdb: 1217] [UniProtKB: Q86VL8] | ||||||||
| ChEMBL | Inhibition of human MATE2K-mediated ASP+ uptake expressed in HEK293 cells after 1.5 mins by fluorescence assay | B | 5.12 | pIC50 | 7600 | nM | IC50 | J Med Chem (2013) 56: 781-795 [PMID:23241029] |
| μ receptor/Mu opioid receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL233] [GtoPdb: 319] [UniProtKB: P35372] | ||||||||
| ChEMBL | Inhibitory concentration against Opioid receptor mu 1 | B | 5 | pIC50 | >10000 | nM | IC50 | Bioorg Med Chem Lett (1995) 5: 1377-1382 |
| Peroxisome proliferator-activated receptor-γ/Peroxisome proliferator-activated receptor gamma in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL235] [GtoPdb: 595] [UniProtKB: P37231] | ||||||||
| GtoPdb | - | - | 5.61 | pEC50 | 2440 | nM | EC50 | J Med Chem (2018) 61: 5758-5764 [PMID:29878767] |
| ChEMBL | Partial agonist activity at human PPARgamma LBD expressed HEK293T cells after 12 to 14 hrs by dual-glo luciferase reporter gene assay | B | 5.61 | pEC50 | 2440 | nM | EC50 | J Med Chem (2018) 61: 5758-5764 [PMID:29878767] |
| Platelet activating factor receptor in Guinea pig (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5136] [UniProtKB: P21556] | ||||||||
| ChEMBL | Displacement of [3H]ligand from platelet activating factor (PAF) receptor in rabbit platelets | B | 4.3 | pKi | >50000 | nM | Ki | Bioorg Med Chem Lett (1995) 5: 1377-1382 |
| mPGES1/Prostaglandin E synthase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5658] [GtoPdb: 1377] [UniProtKB: O14684] | ||||||||
| ChEMBL | Inhibition of microsomal PGES1 in ILbeta/TNFalpha-stimulated human A549 cells using PGH2 as substrate preincubated for 15 mins followed by substrate addition measured after 1 min by LC-MS/MS analysis | B | 4.74 | pIC50 | 18100 | nM | IC50 | Medchemcomm (2015) 6: 2081-2123 |
| Organic cation transporter 2/Solute carrier family 22 member 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1743122] [GtoPdb: 1020] [UniProtKB: O15244] | ||||||||
| ChEMBL | Inhibition of human OCT2-mediated ASP+ uptake expressed in HEK293 cells after 3 mins by fluorescence assay | B | 5.01 | pIC50 | 9700 | nM | IC50 | J Med Chem (2013) 56: 781-795 [PMID:23241029] |
| CYP5A1/Thromboxane-A synthase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1835] [GtoPdb: 1353] [UniProtKB: P24557] | ||||||||
| ChEMBL | DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2) | B | 5.42 | pIC50 | 3810 | nM | IC50 | DrugMatrix in vitro pharmacology data |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]
